Retina Implant AG's Alpha IMS Wins CE Mark | 合法醫療器材資訊網

2019年4月11日 — Retina Implant AG shareholders decided to dissolve the company March 19, 2019, at a general meeting. The German company announced the ... Read More

Retina Implant's technology, which has been in clinical trials across the world since 2005, is designed to restore useful vision in patients blinded by the ... Read More

Retina Implant AG in Germany has also developed a subretinal implant, which has undergone clinical testing in nine patients. Trial was put on hold due to ... Read More

2019年4月4日 — Unfortunately, the history of our company is coming to an end. The shareholders of Retina Implant AG resolved to dissolve the company at an ... Read More

PurposeThe subretinal Alpha IMS visual implant is a CE-approved medical device for restoration of visual functions in blind patients with end-stage outer retina ... Read More

2013年2月23日 — According to the press release, “Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), ... Read More

To date, the Alpha IMS subretinal implant from Germany-based Retina Implant AG has been implanted in 38 patients with late-stage retinitis pigmentosa (RP), ... Read More

Retina Implant AG is a medical technology company. The Company is developing a retinal prosthesis for blind patients to gain back lost sight. Read More

Retina Implant AG. Home時間表Retina Implant AG. IDTechEx:66025. Retina Implant AG. Website. retina-implant.de... HQ Country. Germany. 線上即時資料庫 ... Read More